Duchenne muscular dystrophy trials in New Zealand

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy

  Where

  Auckland, Christchurch

  Age

  9 years and over

  People

  36 worldwide

  Run by

  Keros Therapeutics, Inc.

  See details and how to joinNCT07704099
• Phase 2Enrolling by invitation
  Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

  Where

  Auckland

  People

  260 worldwide

  Run by

  Edgewise Therapeutics, Inc.

  See details and how to joinNCT06066580